BIOMOTION SCIENCES-CW29 (SLXNW:NASDAQ)

$0.0265 0.0014 (5.5777%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 67

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed BIOMOTION SCIENCES-CW29 (SLXNW:NASDAQ) News Sources

Silexion Therapeutics Announces Exercise of Warrants for $1.8 Million Gross Proceeds

01-08-2025

yahoo.com

Silexion Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

12-08-2025

yahoo.com

Silexion Therapeutics Announces Selection of Contract Research Organization to Support Upcoming Phase 2/3 Clinical Trials for SIL204

04-09-2025

yahoo.com

Silexion Therapeutics Reports Positive Preclinical Data Demonstrating SIL204’s Reach and Activity in Major Pancreatic Cancer Metastatic Sites Following Systemic Administration

11-09-2025

yahoo.com

Silexion Therapeutics Announces Pricing of $6.0 Million Public Offering

11-09-2025

yahoo.com

Silexion Therapeutics Regains Compliance with Nasdaq Listing Requirements

25-09-2025

yahoo.com

Silexion Therapeutics Announces Positive New Human Cell Line Data Confirming Pan-KRAS Activity of SIL204, Demonstrating Up to 99.7% Inhibition and First Evidence in Gastric Cancer

30-09-2025

yahoo.com

Silexion Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

12-11-2025

yahoo.com

Silexion Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

17-03-2026

yahoo.com

Silexion Therapeutics Receives Approval from Israeli Ministry of Health to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer

24-03-2026

yahoo.com

BIOMOTION SCIENCES-CW29 (SLXNW:NASDAQ) Sentiment Trend

0 25 50 75 100 58 65 57 77 76 57 59 85 69 68 01-08-2025 12-08-2025 04-09-2025 11-09-2025 25-09-2025 30-09-2025 12-11-2025 17-03-2026 24-03-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

BIOMOTION SCIENCES-CW29 (SLXNW:NASDAQ) FAQs

toggle

What is the current price of BIOMOTION SCIENCES-CW29 (SLXNW:NASDAQ)?

The current price of BIOMOTION SCIENCES-CW29 (SLXNW:NASDAQ) is $0.0265.


toggle

BIOMOTION SCIENCES-CW29 (SLXNW:NASDAQ) absolute price change since previous trading day?

The absolute price change of BIOMOTION SCIENCES-CW29 (SLXNW:NASDAQ) since the previous trading day is $0.0014.


toggle

BIOMOTION SCIENCES-CW29 (SLXNW:NASDAQ) percentage price change since previous trading day?

The percentage price change of BIOMOTION SCIENCES-CW29 (SLXNW:NASDAQ) since the previous trading day is 5.5777%.


toggle

What is the most recent average sentiment score for BIOMOTION SCIENCES-CW29 (SLXNW:NASDAQ)?

The most recent average sentiment score for BIOMOTION SCIENCES-CW29 (SLXNW:NASDAQ) is 67 out of 100.


toggle

What is the most recent average sentiment for BIOMOTION SCIENCES-CW29 (SLXNW:NASDAQ)?

The most recent sentiment for BIOMOTION SCIENCES-CW29 (SLXNW:NASDAQ) is .


SEC-8K** Filing Available For BIOMOTION SCIENCES-CW29 (SLXNW:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.